Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04953715 · ClinicalTrials.gov registry record
Microbiome and Immunosuppression: The Mission Study
A clinical trial of Kidney Transplant and Kidney Transplant Rejection, sponsored by The University of Texas Medical Branch, Galveston.
- Active
- Registry status
- 140
- Enrollment target
- 2
- Study locations
NCT04953715 is a study of Kidney Transplant and Kidney Transplant Rejection that is active but no longer recruiting, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 140 participants, below the 1,894-participant average among 30 other Kidney Transplant trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04953715, a study of Kidney Transplant and Kidney Transplant Rejection, is active but no longer recruiting, sponsored by The University of Texas Medical Branch, Galveston.
- ACTIVE NOT RECRUITING
- Registry status
- 140 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research is to study immunosuppression drugs, certain foods, and how they can change the microbiome (the natural microorganisms inside the body) of the individual taking the immunosuppressive medications. The study team wants to study how the microbiome affects how the body processes the transplant medication.
Conditions Studied
Interventions
- OTHER collection of body microbiome
Study Locations (2)
Minnesota
- University of Minnesota - Minneapolis
- HCMC - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2033-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04953715
The ClinicalTrials.gov registry entry for NCT04953715 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,894-participant average among 30 other Kidney Transplant trials with a reported enrollment target (93% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Kidney Transplant appearing as the primary indexed condition, and to 1 intervention - of which collection of body microbiome is the first listed.
NCT04953715 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04953715 about?
NCT04953715 is a clinical study titled "Microbiome and Immunosuppression: The Mission Study". The purpose of this research is to study immunosuppression drugs, certain foods, and how they can change the microbiome (the natural microorganisms inside the body) of the individual taking the immunosuppressive medications. The study team wants to study how the microbiome affects how the body proce...
What is the current status of trial NCT04953715?
This trial is currently active not recruiting. The enrollment target is 140 participants. The study started on 2020-02-12. Estimated completion is 2033-01-01.
What conditions does trial NCT04953715 study?
This clinical trial studies the following conditions: Kidney Transplant, Kidney Transplant Rejection.
What interventions are being tested in trial NCT04953715?
The interventions under investigation include: collection of body microbiome (OTHER).
Who is sponsoring clinical trial NCT04953715?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04953715 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
Social Support Counseling Intervention for Kidney Transplant Candidates
RECRUITING · NA
-
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
RECRUITING · Phase 3
-
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
RECRUITING · Phase 3
-
Advancing Transplantation Outcomes in Children
RECRUITING · Phase 2
-
Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.